Phase I/II Trial to Investigate BI 836858 in Myelodysplastic Syndromes
Clinical trial NCT02240706 · TERMINATED
Trial details
- NCT number
- NCT02240706
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-22
- Primary completion
- 2019-11-18
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.